TH-E-ValB-03: Tumor Volume Regression During Radiation Therapy to Predict Treatment Outcome for Cervical Cancer

2006 ◽  
Vol 33 (6Part23) ◽  
pp. 2289-2290
Author(s):  
J Wang ◽  
N Mayr ◽  
W Yuh ◽  
H Zhang ◽  
J Montebello ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Radiation Therapy ◽  
Treatment Outcome ◽  
Tumor Volume

PO-1693: Correlation between SUVmax and Primary Tumor Volume in Cervical Cancer Received Radiation Therapy

2020 ◽  
Vol 152 ◽  
pp. S932-S933
Author(s):  
H. Lee ◽  
S.G. Kim ◽  
Y.S. Shim ◽  
Y.S. Kim ◽  
J.W. Shin ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Radiation Therapy ◽  
Primary Tumor ◽  
Tumor Volume ◽  
Primary Tumor Volume

Brachytherapy for Locally Advanced Cervix Cancer (Methodological Aspects)

2019 ◽  
Vol 64 (5) ◽  
pp. 76-80
Author(s):  
О. Кравец ◽  
O. Kravets ◽  
А. Дубинина ◽  
A. Dubinina ◽  
Е. Тарачкова ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Radiation Therapy ◽  
Tumor Volume ◽  
Maximum Dose ◽  
Locally Advanced ◽  
External Beam Radiation ◽  
High Dose ◽  
Advanced Cervical Cancer ◽  
Beam Radiation ◽  
Locally Advanced Cervical Cancer

Purpose: To increase local control of cervical tumors by developing and introducing into practice the optimization of dose distribution in the primary tumor during concomitant chemoradiation (CRT) and image-guided adaptive brachytherapy (IGABT) i.e. summing up the maximum dose to the tumor volume of HR-CTV> 85 Gy in the shortest possible period of time by the optimal fractionation regime, without increasing the tolerable doses to the organs of risk (bladder, rectum, sigmoid). Material and methods: Data of the study was the of clinical observations of patients with locally advanced cervical cancer proven stage IIb–IIIb according to FIGO, treated with curative radiation therapy. After pelvic +/- para-aortic external-beam radiation therapy (2 Gy × 50 Gy with Cisplatin 40 mg/m2 weekly), they received high-dose rate intracavitary brachytherapy or in combination with interstitial component following GEC-ESTRO recommendations. Results: We managed to achieve maximum dose to the tumor volume of HR-CTV> 85 Gy without increasing the load on the risk organs. The Clinical Contouring at the time of primary diagnosis of cervical cancer and before brachytherapy session based on clinical and diagnostic data using MRI helps to optimize the brachytherapy process, develop patient management tactics and a clear sequence of actions in a complex program of brachytherapy. Conclusion: The presented clinical cases indicate the prospects of using an individual approach in planning the brachytherapy of patients with locally advanced cervical cancer.

Sign in / Sign up

Export Citation Format

Share Document